Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal‐dominant polycystic kidney disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Genetics

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1399-0004.2010.01555.xPMID 20950398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.

  2009cited by this paper
• Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease

  2009cited by this paper
• Function and regulation of TRPP2 at the plasma membrane.

  2009cited by this paper
• Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney disease.

  2009cited by this paper
• Evidence for pathogenicity of atypical splice mutations in autosomal dominant polycystic kidney disease.

  2009cited by this paper
• Variation in age at ESRD in autosomal dominant polycystic kidney disease.

  2008cited by this paper
• Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker

  2008cited by this paper
• Autosomal dominant polycystic kidney disease: time for a change?

  2007cited by this paper
• Splicing in disease: disruption of the splicing code and the decoding machinery

  2007cited by this paper
• Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics.

  2007cited by this paper
• Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

  2007cited by this paper
• Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.

  2007cited by this paper
• An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers.

  2006cited by this paper
• An Alternative Spliced RNASEL Variant in Peripheral Blood Leukocytes

  2006cited by this paper
• Molecular pathogenesis of ADPKD: the polycystin complex gets complex.

  2005cited by this paper
• A splice form of polycystin-2, lacking exon 7, does not interact with polycystin-1.

  2005cited by this paper
• Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics

  2004cited by this paper
• ESEfinder: a web resource to identify exonic splicing enhancers

  2003cited by this paper
• Listening to silence and understanding nonsense: exonic mutations that affect splicing

  2002cited by this paper
• Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1.

  2000cited by this paper
• Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease.

  1999cited by this paper
• Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.

  1999cited by this paper
• The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.

  1998cited by this paper
• Improved Splice Site Detection in Genie

  1997influential reference
• Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2).

  1997cited by this paper
• The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences

  1992cited by this paper
• Autosomal dominant polycystic kidney disease

  1992cited by this paper
• Genetic heterogeneity of polycystic kidney disease in Europe.

  1992cited by this paper

• Single-Base Substitution Causing Dual-Exon Skipping Event in PKD2 Gene: Unusual Molecular Finding from Exome Sequencing in a Patient with Autosomal Dominant Polycystic Kidney Disease

  2024cites this paper
• Identified eleven exon variants in PKD1 and PKD2 genes that altered RNA splicing by minigene assay

  2023cites this paper
• Identified eleven exon variants in PKD1 and PKD2 genes that altered RNA splicing by minigene assay

  2023cites this paper
• The diverse effects of pathogenic point mutations on ion channel activity of a gain-of-function polycystin-2

  2023cites this paper
• Polycystin-2 (TRPP2): Ion Channel Properties and Regulation.

  2022cites this paper
• A common intronic single nucleotide variant modifies PKD1 expression level

  2022cites this paper
• A new atypical splice mutation in PKD2 leading to autosomal dominant polycystic kidney disease in a Chinese family

  2021influential citation
• A Presumed Synonymous Mutation of PKD2 Caused Autosomal Dominant Polycystic Kidney Disease in a Chinese Family

  2021cites this paper
• Adaptive selection drives TRPP3 loss-of-function in an Ethiopian population

  2020cites this paper
• Nephrogenetics and Nephrodiagnostics: Contemporary Molecular Approaches in the Genomics Era

  2018cites this paper
• Papillary renal cell carcinoma with a somatic mutation in MET in a patient with autosomal dominant polycystic kidney disease.

  2016cites this paper
• Three exonic mutations in polycystic kidney disease-2 gene (PKD2) alter splicing of its pre-mRNA in a minigene system.

  2016cites this paper
• Polycystic Kidney Disease: A Paradigm in Major Kidney Disorders

  2015influential citation
• Autosomal dominant polycystic kidney disease: genetics, mutations and microRNAs.

  2011cites this paper